Relevant bibliographies by topics / Pyridopyrimidinic inhibitors

Contents

  1. Journal articles
  2. Dissertations / Theses

Academic literature on the topic 'Pyridopyrimidinic inhibitors'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pyridopyrimidinic inhibitors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pyridopyrimidinic inhibitors"

1

Du, Xi Hhua, and Wen Chang Zhuang. "Neural Network Model for Predicting Anticancer Activity of Pyridopyrimidines Derivatives." Advanced Materials Research 905 (April 2014): 96–100. http://dx.doi.org/10.4028/www.scientific.net/amr.905.96.

Full text
Abstract:
Molecular structures of pyridopyrimidines derivatives as known as dihydrofolate reductase (DHFR) inhibitors were investigated by using the neural network method. Based on the molecular connectivity, molecular connectivity index and molecular electronegativity distance vectors of 32 pyridopyrimidine derivatives were obtained. Among these parameters, three optimized structural parameters 1χ3χ and M17 as the input neurons of the artificial neural network were selected by step-wise regression. Then a 3:4:1 network architecture was employed and a satisfying neural network model for predicting antic
APA, Harvard, Vancouver, ISO, and other styles
2

Rosse, Gerard. "Pyridopyrimidines as Inhibitors of Hepatitis C Virus." ACS Medicinal Chemistry Letters 5, no. 3 (2013): 226–27. http://dx.doi.org/10.1021/ml4004149.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Zheng, Guo Zhu, Chih-Hung Lee, John K. Pratt, et al. "Pyridopyrimidine analogues as novel adenosine kinase inhibitors." Bioorganic & Medicinal Chemistry Letters 11, no. 16 (2001): 2071–74. http://dx.doi.org/10.1016/s0960-894x(01)00375-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wu, Zhicai, John C. Hartnett, Lou Anne Neilson, et al. "Development of Pyridopyrimidines as Potent Akt1/2 Inhibitors." Bioorganic & Medicinal Chemistry Letters 18, no. 4 (2008): 1274–79. http://dx.doi.org/10.1016/j.bmcl.2008.01.054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Slivka, Mikhail V., and Natalia I. Korol. "Condensed Pyridopyrimidines and Pyridopyrazines Containing a Bridgehead Nitrogen Atom: Synthesis, Chemical Properties and Biological Activity." Current Organic Chemistry 25, no. 12 (2021): 1429–40. http://dx.doi.org/10.2174/1385272825666210525154330.

Full text
Abstract:
The investigation of effective and green synthetic routes to approach to novel fused heterocycles with pyridopyrimidine and pyridopyrazine scaffolds stirs up broad interest from scientists as they are capable of providing valuable properties such as anticancer and antimicrobial activities and they are proved γ-secretase modulators, polymers, and corrosion inhibitors. This causes a steady increase in the number of publications on titled condensed systems. The present review article summarizes recent literature data from 2010 to 2020 on the methods of synthesis, chemical transformations and biol
APA, Harvard, Vancouver, ISO, and other styles
6

Zheng, Guo Zhu, and et al et al. "ChemInform Abstract: Pyridopyrimidine Analogues as Novel Adenosine Kinase Inhibitors." ChemInform 32, no. 45 (2010): no. http://dx.doi.org/10.1002/chin.200145170.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cowart, Marlon, Chih-Hung Lee, Gregory A. Gfesser, et al. "Structure–activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors." Bioorganic & Medicinal Chemistry Letters 11, no. 1 (2001): 83–86. http://dx.doi.org/10.1016/s0960-894x(00)00602-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Andrews, Logan D., Timothy R. Kane, Paola Dozzo, et al. "Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase." Journal of Medicinal Chemistry 62, no. 16 (2019): 7489–505. http://dx.doi.org/10.1021/acs.jmedchem.9b00625.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Labadie, Sharada, Kathy Barrett, Wade S. Blair, et al. "Design and evaluation of novel 8-oxo-pyridopyrimidine Jak1/2 inhibitors." Bioorganic & Medicinal Chemistry Letters 23, no. 21 (2013): 5923–30. http://dx.doi.org/10.1016/j.bmcl.2013.08.082.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Guiles, Joseph W., Andras Toro, Urs A. Ochsner, and James M. Bullard. "Development of 4H-pyridopyrimidines: a class of selective bacterial protein synthesis inhibitors." Organic and Medicinal Chemistry Letters 2, no. 1 (2012): 5. http://dx.doi.org/10.1186/2191-2858-2-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pyridopyrimidinic inhibitors"

1

Saurat, Thibault. "Synthèse d’inhibiteurs pyridopyrimidiniques de la voie PI3K/Akt/mTOR et mise au point de tests enzymatiques dans l’évaluation de leurs activités inhibitrices." Thesis, Orléans, 2012. http://www.theses.fr/2012ORLE2007.

Full text
Abstract:
Devant l’incidence de la suractivation de la voie PI3K/Akt/mTOR sur les cancers, nous avons choisi d’inhiber cette voie de signalisation. Etant donné la forte analogie structurale qui existe entre les enzymes PI3K et mTOR, nous avons conçu des inhibiteurs doubles ciblant deux kinases majeures de la voie. Ces inhibiteurs possèdent un noyau original pyrido[3,2-d]pyrimidinique. Afin d’apporter de la diversité fonctionnelle et d’engendrer un effet thérapeutique, les sommets C-4, C-2 et C-7 furent fonctionnalisé séquentiellement selon l’ordre suivant. Tout d’abord, la position C-4 fut fonctionnalis
APA, Harvard, Vancouver, ISO, and other styles
2

Dehbi, Oussama. "Synthèse de nouveaux dérivés pyridopyrimidiniques, imidazopyridiniques et imidazopyridaziniques : évaluation de leurs propriétés biologiques." Thesis, Orléans, 2012. http://www.theses.fr/2012ORLE2078/document.

Full text
Abstract:
Les produits appartenant à la famille des pyridopyrimidines sont caractérisés par leur intense utilisation dans le domaine pharmacologique, ce qui a poussé différentes équipes de recherche, de par le monde, à les étudier chimiquement et biologiquement. Dans ce travail, nous nous sommes intéressés au groupe des pyridopyrimidines et, plus particulièrement, à l’isomère le moins décrit dans la littérature, à savoir les pyrido[3,2-d]pyrimidines. Les composés ciblés sont synthétisés à partir de la 2,7-dichloropyrido[3,2-d]pyrimidine, via des substitutions nucléophiles aromatiques et des couplages pa
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pyridopyrimidinic inhibitors' for particular source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography